BioCryst Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 156.4M | 406.6M | 159.4M | 163.4M | 145.5M | 131.5M | 117.1M | 109.3M |
| Cost of Goods Sold | 703.1M | 9.9M | 2.5M | 2.8M | 4.6M | 6.1M | 3.2M | 1.7M |
| Gross Profit | -546.7M | 396.6M | 156.9M | 160.6M | 141.0M | 125.4M | 113.9M | 107.6M |
| R&D Expenses | 60.3M | 41.2M | 44.3M | 43.4M | 37.3M | 49.4M | 41.1M | 37.6M |
| Operating Expenses | 154.9M | 136.6M | 127.3M | 130.8M | 119.7M | 129.9M | 106.2M | 98.9M |
| Operating Income | -701.6M | 260.4M | 29.6M | 29.8M | 21.2M | -4.5M | 7.7M | 8.8M |
| Other Income / Gains | -19.2M | -12.4M | -17.5M | -23.3M | -20.5M | -21.5M | -21.1M | -21.3M |
| Net Income | -721.8M | 245.8M | 12.9M | 5.1M | 32K | -26.8M | -14.0M | -12.7M |
| EPS (Diluted) | -2.98 | 1.17 | 0.061 | 0.02 | 0 | -0.13 | -0.07 | -0.06 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | -3.495 | 0.976 | 0.984 | 0.983 | 0.969 | 0.953 | 0.972 | 0.984 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 94.6M | 95.8M | 83.0M | 87.4M | 82.5M | 80.5M | 65.1M | 61.2M |
| Other Expenses | 0 | -335K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 858.0M | 146.2M | 129.8M | 133.6M | 124.3M | 136.0M | 109.4M | 100.6M |
| Interest Income | 2.3M | 2.9M | 2.2M | 2.5M | 3.0M | 3.6M | 3.6M | 3.6M |
| Interest Expense | 19.8M | 14.1M | 19.7M | 21.6M | 23.5M | 24.4M | 24.8M | 24.7M |
| Depreciation And Amortization | 1.1M | 4.0M | 335K | 329K | 331K | 309K | 311K | 320K |
| Ebitda | -700.0M | 266.2M | 32.1M | 28.4M | 24.6M | -1.2M | 11.7M | 12.6M |
| Ebitdaratio | -4.475 | 0.655 | 0.202 | 0.174 | 0.169 | -0.009 | 0.10 | 0.115 |
| Operating Income Ratio | -4.486 | 0.64 | 0.186 | 0.182 | 0.146 | -0.034 | 0.066 | 0.08 |
| Income Before Tax | -720.8M | 248.0M | 12.1M | 6.5M | 758K | -26.0M | -13.4M | -12.5M |
| Income Before Tax Ratio | -4.608 | 0.61 | 0.076 | 0.04 | 0.005 | -0.198 | -0.115 | -0.114 |
| Income Tax Expense | 1.0M | 2.2M | -769K | 1.4M | 726K | 804K | 586K | 172K |
| Net Income Ratio | -4.615 | 0.605 | 0.081 | 0.031 | 0.00 | -0.204 | -0.12 | -0.116 |
| Epsdiluted | -2.98 | 1.12 | 0.059 | 0.02 | 0 | -0.13 | -0.07 | -0.06 |
| Weighted Average Shs Out | 242.3M | 211.0M | 210.2M | 209.5M | 208.9M | 207.4M | 206.9M | 206.4M |
| Weighted Average Shs Out Dil | 242.3M | 219.3M | 219.9M | 219.9M | 215.3M | 207.4M | 206.9M | 206.4M |